HOLLY KALISH: Open Payments
NPI 1306334909 · HOCKESSIN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 39 payments from 15 companies in 2025. Trend: 2023 $212 · 2024 $680 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| ABBVIE INC. | 8 | $145 |
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 4 | $73 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: FARXIGA, VRAYLAR, MOUNJARO, BREZTRI, Wegovy, VOQUEZNA, JARDIANCE, GARDASIL 9.
Industry payments across DE — which companies pay providers there.
